Nektar Therapeutics
San Francisco · Founded 1990
About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.
Company Facts
- Founded: 1990
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $1.8B
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:NKTR
- Website: http://www.nektar.com
- Phone: (650)631-3100
Industries & Categories
Biotechnology, Chemical, Health Care, Therapeutics
Investment Activity
- 1 exit(s)
Social Profiles
Canonical: https://fsome.com/organization/nektar-therapeutics-69301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.